Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nomad Bioscience develops plant-made biomaterials and biopharmaceuticals with a focus on antibacterial precision biologics for multidrug resistant Gram-negative bacteria. The company also works on antiviral biologics, food antibacterials, sweet/taste modifying proteins, and industrial enzymes. Its pipeline includes preclinical candidates for infectious disease control in medicine and food safety applications. The company has filed patents related to bacteriocins for controlling Salmonella enterica.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nomadworks.